| 000 | 01713 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517164032.0 | ||
| 264 | 0 | _c20171009 | |
| 008 | 201710s 0 0 eng d | ||
| 022 | _a1083-351X | ||
| 024 | 7 |
_a10.1074/jbc.M116.771485 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGajiwala, Ketan S | |
| 245 | 0 | 0 |
_aThe Axl kinase domain in complex with a macrocyclic inhibitor offers first structural insights into an active TAM receptor kinase. _h[electronic resource] |
| 260 |
_bThe Journal of biological chemistry _c09 2017 |
||
| 300 |
_a15705-15716 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 |
_aCell Membrane _xenzymology |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aEnzyme Stability |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 |
_aMacrocyclic Compounds _xmetabolism |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 | _aProtein Domains |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xmetabolism |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAxl Receptor Tyrosine Kinase |
| 700 | 1 | _aGrodsky, Neil | |
| 700 | 1 | _aBolaños, Ben | |
| 700 | 1 | _aFeng, Junli | |
| 700 | 1 | _aFerre, RoseAnn | |
| 700 | 1 | _aTimofeevski, Sergei | |
| 700 | 1 | _aXu, Meirong | |
| 700 | 1 | _aMurray, Brion W | |
| 700 | 1 | _aJohnson, Ted W | |
| 700 | 1 | _aStewart, Al | |
| 773 | 0 |
_tThe Journal of biological chemistry _gvol. 292 _gno. 38 _gp. 15705-15716 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1074/jbc.M116.771485 _zAvailable from publisher's website |
| 999 |
_c27383940 _d27383940 |
||